Syllabus for Introduction to Nanomedicine
Introduktion till nanomedicin
- 7.5 credits
- Course code: 3FG013
- Education cycle: Second cycle
-
Main field(s) of study and in-depth level:
Pharmaceutical Sciences A1N,
Drug Discovery and Development A1N
Explanation of codes
The code indicates the education cycle and in-depth level of the course in relation to other courses within the same main field of study according to the requirements for general degrees:
First cycle
- G1N: has only upper-secondary level entry requirements
- G1F: has less than 60 credits in first-cycle course/s as entry requirements
- G1E: contains specially designed degree project for Higher Education Diploma
- G2F: has at least 60 credits in first-cycle course/s as entry requirements
- G2E: has at least 60 credits in first-cycle course/s as entry requirements, contains degree project for Bachelor of Arts/Bachelor of Science
- GXX: in-depth level of the course cannot be classified
Second cycle
- A1N: has only first-cycle course/s as entry requirements
- A1F: has second-cycle course/s as entry requirements
- A1E: contains degree project for Master of Arts/Master of Science (60 credits)
- A2E: contains degree project for Master of Arts/Master of Science (120 credits)
- AXX: in-depth level of the course cannot be classified
- Grading system: Fail (U), Pass (G), Pass with distinction (VG)
- Established: 2020-10-20
- Established by: The Educational Board of Pharmacy
- Revised: 2022-08-25
- Revised by: The Educational Board of Pharmacy
- Applies from: Autumn 2023
-
Entry requirements:
150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Responsible department: Department of Pharmacy
Learning outcomes
After course completion, the student should:
- Explain and discuss advantages and challenges with nanomaterials in medical and pharmaceutical applications
- Describe transport mechanisms as well as passive and active targeting that control uptake of nano-based drug delivery systems via different administration routes
- Describe and critically evaluate different types of nanovehicles and nanocarriers as well as their use in nanomedicine for disease diagnosis and therapy
- Account for toxic, pharmacokinetic and regulatory aspects for the development of nano-based drug delivery systems
- Utilize, reflect over, summarize in written and orally present relevant scientific literature within nanomedicine, in correct English.
Content
The course covers the principles in nanomedicine, especially with regard to the connection between physicochemical properties of nanomaterials, possible administration routes and their interactions with cells and tissues in the body. Further, it deals with the behavior of nanoparticles in biological fluids (e.g. plasma, intestinal fluid) and colloidal stability. We study the basic principles for active (with ligands) and passive (e.g. for cancer therapy) targeting and uptake of nanoparticles in cells and tissues in the body. Furthermore, the course will cover nanoparticle and nanocarrier properties including the most important synthesis routes and characterization methods. Special focus is also on diagnostic materials that can be used in imaging techniques or in theranostic formulations that combine disease diagnosis and therapy. Finally, we will consider toxic, pharmacokinetic and regulatory aspects of nanomaterials in biomedical applications. For toxicity this includes a comparison of different external barriers that are exposed to nanomaterials, e.g. in the intestine, lungs, nose and skin.
Instruction
Teaching is in the form of lectures, discussion seminars and a literature study. Certain parts of the instruction will be carried out digitally.
The course is given in English.
Discussion seminars and the literature study are compulsory.
Assessment
An oral examination is conducted at the end of the course. The following is required to pass the course: passed oral examination (6 hp) and passed on compulsory parts of the course (literature study: 1 hp, discussion seminars: 0.5 hp).
If special reasons apply, the examiner may make exceptions from the described examination and allow a student to be assessed differently. An example of special reasons might be a certificate regarding special pedagogical support from the coordinator of the university.
Syllabus Revisions
- Latest syllabus (applies from Autumn 2023)
- Previous syllabus (applies from Autumn 2021)
Reading list
The reading list is missing. For further information, please contact the responsible department.